Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-511X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) ; volume:10 ; number:1 ; day:10 ; month:6 ; year:2011 ; pages:1-7 ; date:12.2011
Lipids in health and disease ; 10, Heft 1 (10.6.2011), 1-7, 12.2011

Creator: Mata, Nelva
Alonso, Rodrigo
Badimón, Lina
Padró, Teresa
Fuentes, Francisco
Muñiz, Ovidio
Perez-Jiménez, Francisco
López-Miranda, José
Díaz, Jose L.
Vidal, Jose I.
Barba, A.
Piedecausa, Mar
Sanchez, Juan F.
Irigoyen, Luis
Guallar, Eliseo
Ordovas, José M.
Mata, Pedro

Contributor: SpringerLink (Online service)

DOI: 10.1186/1476-511X-10-94

URN: urn:nbn:de:101:1-2019071903492326105656

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Mata, Nelva
Alonso, Rodrigo
Badimón, Lina
Padró, Teresa
Fuentes, Francisco
Muñiz, Ovidio
Perez-Jiménez, Francisco
López-Miranda, José
Díaz, Jose L.
Vidal, Jose I.
Barba, A.
Piedecausa, Mar
Sanchez, Juan F.
Irigoyen, Luis
Guallar, Eliseo
Ordovas, José M.
Mata, Pedro
SpringerLink (Online service)

Other Objects (12)

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

Quo vadis, LDL cholesterol?

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

Quo vadis, LDL cholesterol?

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

Quo vadis, LDL cholesterol?

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

Quo vadis, LDL cholesterol?

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

Quo vadis, LDL cholesterol?

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL

Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

Quo vadis, LDL cholesterol?

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?

Related objects

Reset password